Medical treatment in India for Uzbek patients
For a patient travelling from Uzbekistan, the journey does not have to begin with an immediate flight. GAF Healthcare helps Uzbek patients share records from Tashkent, Samarkand, Bukhara, Andijan, Fergana, Namangan and other cities with an appropriate Indian specialist, then plan the e-Medical Visa, travel and follow-up around that medical requirement.
Quick answer
Yes. Uzbekistan is currently included in India's official e-Visa eligible-country list, and the Government of India provides e-Medical Visa and e-Medical Attendant Visa categories for eligible applicants.
Yes. India's Ministry of External Affairs has specifically identified Uzbekistan as a significant source of medical tourism to India, reporting approximately 8,000 Uzbek patients annually seeking treatment in India in its bilateral brief.
Depending on the diagnosis, patients may explore cancer treatment, cardiology and cardiac surgery, neurosurgery, orthopaedic surgery, knee and hip replacement, spine surgery, urology, gastroenterology, liver and pancreatic surgery, kidney treatment, organ transplantation, IVF and fertility treatment, paediatric treatment, robotic and minimally invasive surgery, radiation oncology, chemotherapy, immunotherapy, targeted therapy, precision oncology and complex second opinions.
There is no universal treatment price. The final estimate depends on the diagnosis, disease stage, hospital, specialist, procedure, medicines, implants, investigations, ICU requirements, hospital stay and possible complications. A hospital-specific estimate should be obtained after the patient's medical records have been reviewed.
Yes. Medical records, imaging, pathology and previous treatment documents can be shared with an Indian specialist for an initial review. This can help determine whether treatment in India is appropriate and which specialty or hospital may be relevant.
Travelling from Uzbekistan to India for healthcare is a significant decision for the patient and family. The best starting point is not the hospital. It is the medical problem, and which specialist should review it.
The appropriate hospital still depends on the individual patient's medical requirements. India should not automatically be considered appropriate for every patient.
India and Uzbekistan have an established healthcare and pharmaceutical relationship. The official MEA bilateral brief identifies pharmaceutical and healthcare as a high-priority area. The first meeting of the Joint Working Group on Pharmaceutical and Healthcare was held in Tashkent alongside the 11th Inter-Governmental Commission in August 2018, and Indian investment in pharmaceuticals and medical care has been a major focus.
During President Shavkat Mirziyoyev's visit to India in September–October 2018, 17 agreements and MoUs were signed, including in health and medical science and pharmaceuticals.
The same official brief records that India gifted hydroxychloroquine and paracetamol tablets requested by Uzbekistan during COVID-19, conducted e-ITEC programmes for Uzbek medical professionals, and delivered 660,000 doses of Covishield from the Serum Institute of India to Uzbekistan under COVAX on 17 March 2021.
On tourism, the official brief states that an e-Visa scheme was introduced for Uzbek nationals on 1 April 2017 and that Uzbekistan has emerged as a significant source of medical tourism, with about 8,000 Uzbeks annually seeking medical treatment in India. These are published bilateral figures, not a live 2026 patient count.
Uzbekistan is also one of the five Central Asian countries that attended the first India–Central Asia Summit on 27 January 2022. The first ministerial India–Central Asia Dialogue was held in Samarkand in January 2019. These regional frameworks provide useful context. They do not determine which treatment is appropriate for an individual patient.
The Embassy of India in Tashkent currently publishes e-Visa notes for Uzbek nationals and regular visa-service information for applicants who still need the Embassy route.
MEA India–Uzbekistan briefEmbassy of India, TashkentEmbassy visa servicesEmbassy e-Visa notes for Uzbek nationals
Uzbekistan has public and private healthcare services, while some patients still travel when they want a particular subspecialist, a second opinion, an advanced procedure or a multidisciplinary pathway they have chosen to access in India.
Country-level health indicators do not determine an individual's medical needs. The relevant question is: what is the patient's diagnosis, what treatment is appropriate, and can the patient safely travel for that treatment?
Indian hospitals provide specialist care across a wide range of medical disciplines. The appropriate treatment depends on the patient's diagnosis, stage of disease, previous treatment and overall clinical condition.
Each card links only to a live GAF specialty or treatment page. Where GAF does not yet publish a dedicated page, the category is explained without an invented URL.
Medical, surgical and radiation oncology, including breast, colorectal, cervical, prostate and lymphoma pathways that already have GAF guides. Stomach-cancer, lung-cancer and liver-cancer cases are coordinated after records review because dedicated pages are not yet published.
Breast cancer treatment in IndiaAngiography, angioplasty, bypass surgery, valve repair or replacement, TAVR in selected patients, pacemaker or ICD implantation and selected paediatric cardiac operations.
CABG surgery in IndiaBrain-tumour surgery, craniotomy, endoscopic and pituitary procedures, hydrocephalus, aneurysm evaluation and complex spine surgery.
Brain tumour surgery in IndiaKnee and hip replacement, revision joint replacement, ACL reconstruction, arthroscopy and rehabilitation planning.
Knee replacement in IndiaProstate and kidney cancer surgery, stone and prostate procedures, and kidney-transplant evaluation.
Radical prostatectomy in IndiaComplex abdominal and HPB surgery, including Whipple and HIPEC where clinically appropriate.
Whipple surgery in IndiaPaediatric cardiology and cardiac surgery, oncology, neurosurgery and related children’s services. A specialist should assess whether international travel is medically appropriate before the family makes arrangements.
VSD surgery in IndiaKidney and bone-marrow programmes are highly regulated. Donor eligibility, relationship requirements, documentation and legal approvals must be confirmed before travel. A quotation alone does not establish transplant eligibility.
Bone marrow transplant in IndiaUzbek couples may explore IVF, ICSI, IUI and related fertility evaluation in India. GAF does not yet publish a dedicated IVF page. Eligibility, laboratory procedures and applicable Indian regulations should be confirmed with the treating fertility centre before travel.
Sleeve gastrectomy and gastric bypass for selected patients after nutritional and medical review.
Sleeve gastrectomy in India
Breast cancer treatment in India is planned from pathology — surgery, chemotherapy, radiation, hormone therapy, targeted therapy or immunotherapy — not from a single package price.
Colon cancer treatment in India is planned from stage, pathology and molecular profile — colectomy, chemotherapy, targeted therapy or immunotherapy — not from a single package price.
Cervical cancer treatment in India is planned from FIGO stage, fertility goals and whether surgery or chemoradiation with brachytherapy is the right path — not a single package price.
Prostate cancer treatment in India is planned from stage, Grade Group, PSA and imaging — active surveillance, radical prostatectomy, radiation, hormone therapy or systemic care — not from a single package price.
Lymphoma treatment in India is planned by Hodgkin or non-Hodgkin subtype — chemotherapy, radiation, transplant or CAR-T quoted from named GAF sheets.
Chemotherapy in India uses anti-cancer medicines in planned cycles. GAF planning is $1,500–$8,000+, typically outpatient over 3–6 months.
CABG surgery in India is planned from the named bypass product — first-time grafts, redo or mini approaches quoted from named GAF sheets.
Heart valve replacement in India is planned from the named product — surgical replacement, repair or TAVR quoted from named GAF sheets.
Coronary angioplasty in India is planned from the named PCI product — angiography, stenting or CTO work — not a generic heart-stent package.
Brain tumor surgery in India is planned from the named tumour — glioma, meningioma, pituitary, metastasis or biopsy — as maximal safe resection, not a generic brain-surgery package.
Knee replacement in India is planned from X-rays, ligaments and activity goals — total, partial, revision or robotic-assisted arthroplasty — not from a single package price.
Hip replacement in India is planned from pelvis X-rays, bone stock and activity goals — total hip replacement, resurfacing or revision — not from a single package price.
ACL reconstruction in India is planned from MRI, knee stability and sport goals — graft choice, meniscus work and criteria-based rehab — not from a single package price.
Whipple surgery in India is planned from resectability and imaging — pancreaticoduodenectomy, reconstruction, ICU stay and any chemotherapy — not from a single package price.
Bone marrow transplant in India (HSCT) replaces blood-forming stem cells — named partner planning of $25,000–$70,000.
Use this directory to move from this country page into GAF’s live treatment, specialty and cost guides. Items without a dedicated page are listed for planning only.
Cancer is one of the most important treatment areas for Uzbek patients seeking specialised healthcare. According to the IARC GLOBOCAN 2024 Uzbekistan fact sheet, the country had an estimated 38,465 new cancer cases, 22,509 cancer deaths and 93,727 five-year prevalent cases. These are GLOBOCAN 2024 estimates, not current 2026 case counts, and they should not be interpreted as an individual's diagnosis or prognosis.
The same official fact sheet ranks breast first among estimated new cases in both sexes (4,793; 12.5%), followed by colorectum (3,586; 9.3%), cervix uteri (3,147; 8.2%), prostate (3,042; 7.9%) and stomach (2,662; 6.9%). Among Uzbek women, breast cancer was the leading site (4,793; 23.6%), followed by cervix. Among Uzbek men, prostate cancer was the leading site (3,042; 16.7%), followed by colorectum and stomach. GAF does not yet publish dedicated stomach-cancer, lung-cancer or liver-cancer pages; those cases are coordinated through the relevant oncology team after records review.
There is no universal treatment price for Uzbek patients. Two patients undergoing the same named procedure can have very different clinical requirements. GAF Healthcare presents costs as USD planning estimates from the live catalogue, not hospital quotations.
The ranges below are GAF Healthcare planning figures from the live cost catalogue. They are not hospital quotations. Ask the hospital which items are included.
| Treatment | Estimated cost | View cost guide |
|---|---|---|
| Chemotherapy | $1,500–$8,000+Outpatient cycles · 3–6 months typical | Cost guide |
| Immunotherapy | $15,000–$45,000Outpatient q2–6 weeks | Cost guide |
| Targeted Therapy | $8,000–$30,000Oral or infusion · months of therapy | Cost guide |
| Hormone Therapy | $1,000–$4,500Outpatient · often years of tablets | Cost guide |
| CABG (Coronary Artery Bypass Grafting) | $5,500–$14,0007–14 nights, then nearby recovery | Cost guide |
| Heart Valve Replacement | $7,000–$18,0008–16 nights | Cost guide |
| Coronary Angioplasty & Stenting | $3,200–$8,5001–3 nights typical | Cost guide |
| Total Knee Replacement | $5,500–$12,0004–7 nights | Cost guide |
| Total Hip Replacement | $6,000–$13,0004–7 nights | Cost guide |
| Brain Tumor Surgery | $6,000–$15,0005–10 nights | Cost guide |
| Kidney Transplantation | $13,000–$25,00010–21 nights; outpatient follow-up in-city | Cost guide |
| Whipple Procedure (Pancreaticoduodenectomy) | $14,000–$32,00010–18 nights | Cost guide |
| Bone Marrow Transplantation | $25,000–$70,0004–8 weeks in or near the unit | Cost guide |
An estimate obtained before travel should be considered a planning figure unless it is explicitly issued as a final quotation by the hospital. The final amount may change after physical examination, additional investigations, changes in treatment plan, medicines, implants, ICU care, complications or longer hospitalization.
Get a treatment-cost review on WhatsAppTwo hospitals can provide different quotations for the same procedure. A lower headline quotation does not necessarily mean a lower total expenditure. Patients should compare the complete treatment plan, doctor, hospital, inclusions and exclusions.
Ask the hospital or coordinator which items are included in the treatment estimate. Comparing the scope of the quotation is more meaningful than comparing only the headline number.
The appropriate city depends on the medical condition and treatment. There is no single Indian city that is appropriate for every Uzbek patient.
India
Delhi, Gurugram and the wider National Capital Region offer extensive tertiary and super-specialty healthcare across oncology, cardiology, cardiac surgery, neurosurgery, orthopaedics, urology, gastroenterology and transplantation.
India
Major hospitals and specialist centres covering oncology, cardiac care, neurosciences, orthopaedics, gastroenterology and transplantation.
India
An established healthcare ecosystem covering cardiology, oncology, neurosurgery, orthopaedics, transplantation and gastroenterology.
India
Tertiary-care services in oncology, cardiology, neurosurgery, transplantation, orthopaedics and urology.
India
Multispecialty and super-specialty services including oncology, cardiology, neurosciences, orthopaedics, urology and fertility.
India
Pune has a significant multispecialty healthcare ecosystem and can be considered for selected treatments. GAF’s live city catalogue does not yet include Pune, so this page does not link to a Pune directory.
Start with the diagnosis. Ask whether the hospital treats the specific disease, whether the required specialty and surgeon or oncologist are available, whether ICU and advanced diagnostics are in place, whether international-patient services exist, whether the quotation is transparent, and what follow-up arrangements are available. The campuses below are drawn from GAF’s live India catalogue, one from each published city.
JCI Accredited
NABH AccreditedApollo Athenaa Women’s Cancer Centre is a small, purpose-built floor in Delhi NCR — about fifty beds, opened in 2025, sitting inside the Apollo system’s JCI and NABH frame. It is not a general hospital. Radiation here is planned around breast and gynaecological work, with IMRT, SBRT, SRS and brachytherapy when those techniques spare what surgery would take. A travelling patient should only land here if the tumour actually belongs on a women’s-cancer list.
Read More →JCI AccreditedNABH AccreditedApollo Hospitals, Navi Mumbai opened in 2016: 500 beds, JCI and NABH, a radiation list that already includes IMRT, IGRT, SRS and SBRT. Navi Mumbai is the Mumbai tab for a reason — same city cluster, a campus used to international second opinions. Consultants here will not invent a stereotactic indication to shorten a hotel stay. Video first; a date if the plan is theirs.
Read More →JCI AccreditedNABH AccreditedApollo Hospital, Chennai is a Haematology campus in Chennai, India on GAF Healthcare's list. It opened in 1983. 745 beds. JCI · NABH accreditation is current. Named haematologists write transplant, CAR-T and marrow-diagnostic protocols here; medical, radiation and surgical oncology sit on the same map when the case needs them. Records on camera first; a date if Chennai is the right city.
Read More →JCI AccreditedNABH AccreditedApollo Hospital, Jubilee Hills has been a Hyderabad landmark since 1988: 550 beds, JCI and NABH, a radiation department directed by a consultant whose name is asked for across Telangana. IMRT, IGRT, SRS and SBRT are everyday. Brachytherapy fellowship sits on the same floor. Fly to Hyderabad for that named list, not for a city you have never seen. Peer review before the ticket.
Read More →JCI AccreditedNABH AccreditedApollo Hospitals, Bannerghatta Road is a 250-bed JCI campus in Bengaluru, open since 2007. Radiation oncology here is a consultant bench: IMRT, IGRT, SRS, SBRT, CyberKnife and brachytherapy depending on who you are matched to. South India Today prizes do not book a course; a peer-reviewed plan does. English-first coordinators, Kannada and Hindi on the ward, a date after records.
Read More →The doctor should be matched to the patient's diagnosis and procedure. A useful structure is specialty, subspecialty, procedure, city, hospital and then doctor. The specialists below are taken from GAF’s live doctor catalogue.
Senior Director & Unit Head - Medical Oncology
Dr. Ajay Sharma is Senior Director & Unit Head - Medical Oncology at BLK-Max Super Speciality Hospital in Delhi NCR, India. He has practised medical oncology in India for 18+ years experience. The systemic list covers C…
View ProfileKey Procedures
Senior Consultant, Surgical Oncology
Dr. Anil K D'Cruz is Senior Consultant in Surgical Oncology at Apollo Athenaa Women's Cancer Centre in the Delhi NCR, with more than 33 years of experience. He has also practised within Apollo Hospitals in Mumbai, Chenn…
View ProfileKey Procedures
Principal Director and Head of Department of Radiation Oncology
Dr. Anil Kumar Anand is Principal Director and Head of the Department of Radiation Oncology at Fortis Memorial Research Institute in Delhi NCR, with more than 33 years of experience. His practice spans both the external…
View ProfileKey Procedures
Director of Cardiology
Dr. Aparna Jaswal is Director of Cardiology at Fortis Escorts Heart Institute in Delhi NCR, India. She has practised interventional and clinical cardiology in India for 19+ years experience. The cardiology list covers C…
View ProfileKey Procedures
Chairman, Cardiac Sciences
Dr. Ajay Kaul is Chairman of Cardiac Sciences at Fortis Hospital, Noida, in Delhi NCR, with more than 38 years of experience. His profile records cardiac surgery together with paediatric cardiac surgery. His list covers…
View ProfileKey Procedures
Executive Director & Head of Department, Neurosurgery
Dr. Sandeep Vaishya is Executive Director & Head of Department, Neurosurgery at Fortis Memorial Research Institute in Delhi NCR, India. He has practised neurosurgery in India for 32+ years experience. GAF Healthcare lis…
View ProfileKey Procedures
Senior Joint Replacement, Sports & Spine Orthopedic Surgeon
Dr. Yash Gulati is Senior Joint Replacement, Sports & Spine Orthopedic Surgeon at Indraprastha Apollo Hospital in Delhi NCR, India. He has practised adult orthopaedics in India for 37+ years experience. GAF Healthcare l…
View ProfileKey Procedures
Chairman of Urology, Renal Care
Dr. Sanjay Gogoi is Chairman of Urology, Renal Care at Medanta - The Medicity in Delhi NCR, India. He has practised urology in India for 27+ years experience. Stone clearance, prostate resection or enucleation, and livi…
View ProfileKey Procedures
Chairman of Gastroenterology & Hepatology — Pan Max and Head of Department
Dr. Ajay Kumar is Chairman of Gastroenterology & Hepatology — Pan Max and Head of Department at BLK-Max Super Speciality Hospital in Delhi NCR, India. He has practised gastroenterology in India for 38+ years experience.…
View ProfileKey Procedures
Director of Paediatric and Adult Congenital Heart Disease
Dr. Ashutosh Marwah is Director of Paediatric and Adult Congenital Heart Disease at Fortis Escorts Heart Institute in Delhi NCR, with more than 28 years of experience. He is listed in pediatric cardiac surgery and cardi…
View ProfileKey Procedures
Uzbekistan is currently listed among the countries eligible for India's e-Visa system. Medical treatment is an eligible purpose. The official portal provides e-Medical and e-Medical Attendant categories. The Embassy of India in Tashkent currently states that e-Visa stands restored to Uzbek nationals in all five sub-categories, including e-Medical and e-Medical Attendant, and that other visa categories can be submitted at the Embassy counter in Tashkent.
Visa rules, fees, documents and entry regulations can change. Verify the current official Indian e-Visa portal and the Embassy of India in Tashkent immediately before applying or travelling.
Official Indian e-Visa portalEmbassy e-Visa notes for Uzbek nationalsEmbassy visa servicesOfficial e-Visa fee listOfficial Indian visa portal
Patients should determine which visa route applies to their circumstances rather than submitting documents based on an outdated third-party checklist. e-Visa enquiries should be made on the official Government of India portal.
Uzbekistan is not listed among yellow-fever endemic countries on India's IHR points-of-entry guidance. A yellow-fever certificate can still be required if the traveller has recently been in, or transited landside through, a listed endemic country.
Confirm the current requirement on the official Indian e-Visa portal, the Bureau of Immigration, India's IHR yellow-fever list and the Embassy of India in Tashkent before travel.
India IHR yellow-fever vaccinationEmbassy e-Visa notes for Uzbek nationalsEmbassy visa servicesBureau of Immigration
For many Uzbek patients, the international medical journey begins in Tashkent and continues through Tashkent International Airport. Patients may also travel from Samarkand, Bukhara, Andijan, Fergana, Namangan, Qarshi, Nukus, Termez or other cities.
| Treatment destination | Likely arrival airport |
|---|---|
| Delhi NCR | Indira Gandhi International Airport |
| Mumbai | Chhatrapati Shivaji Maharaj International Airport |
| Chennai | Chennai International Airport |
| Hyderabad | Rajiv Gandhi International Airport |
| Bengaluru | Kempegowda International Airport |
| Pune | Pune International Airport |
Confirm the current itinerary with the airline or travel provider. Flight options from Tashkent International Airport and connecting hubs change by season.
There is no standard treatment duration. A consultation may require a short stay. Major surgery, cancer treatment, transplantation and rehabilitation may require several weeks or longer. Ask the hospital for an estimated treatment timeline before booking the return flight.
| Treatment | Possible stay |
|---|---|
| Specialist consultation | 2–5 days |
| Diagnostic evaluation | 2–7 days |
| Major surgery | 1–4 weeks or longer |
| Joint replacement | Around 1–3 weeks |
| Cancer surgery | Often 2–4 weeks |
| Radiation or chemotherapy | Depends on protocol |
| IVF | Often several weeks |
| Complex transplant | Several weeks to months |
A complete medical file can make the initial specialist review more useful. Not every patient needs every document. The treating hospital can advise which records are essential.
If pathology slides or tissue blocks are available, the receiving cancer centre can advise whether they should be brought for review.
International patients may need accommodation close to the treating hospital. For patients receiving repeated chemotherapy or radiation therapy, staying close to the hospital can be particularly practical. For patients recovering from major surgery, accessibility and proximity to medical care may be more important than the accommodation's tourist location.
For patients undergoing repeated chemotherapy or radiation therapy, staying near the hospital may reduce daily travel.
Before travelling, discuss low-salt, diabetic, high-protein, post-operative, vegetarian, religious or allergy-related dietary needs with the treating hospital. Patients undergoing cancer treatment or recovering from surgery should follow the dietary plan provided by their treating team.
Uzbek is the official language of Uzbekistan, and Russian is widely used. Indian hospitals generally use English for medical documentation and specialist consultations. Uzbek- or Russian-language support can be arranged where needed. Patients should never sign medical consent documentation they do not understand.
If you are considering treatment in India, begin with your medical records rather than your flight booking. A records-first sequence allows many questions to be addressed before leaving Tashkent or Samarkand.
Send the relevant reports and a concise medical history.
The appropriate specialist reviews the available records. A remote opinion does not replace an in-person examination.
Discuss the proposed treatment, alternatives and expected timeline.
Choose according to the medical requirement.
The hospital confirms the consultation or treatment pathway.
Request a written estimate showing major inclusions and exclusions.
Use the current official e-Medical Visa process, or the regular Medical Visa through the Embassy of India in Tashkent if that route applies.
Plan flights, accommodation and local transportation around the confirmed hospital schedule.
Proceed to the hospital for consultation and evaluation.
The treating team may repeat or update diagnostic tests before confirming the final plan.
The hospital provides medication and follow-up instructions.
Travel home when medically fit and maintain follow-up with the Indian treating team and local healthcare professionals.
GAF Healthcare can coordinate the medical journey between Uzbekistan and India. The exact services available should be confirmed before travel. Medical decisions remain with the patient and treating medical professionals.
GAF Healthcare's role is to help patients understand and coordinate their options rather than make the clinical decision for them. Visa approval remains subject to the Government of India's rules and decision.
Yes. Patients can often share their medical records with an Indian specialist before deciding to travel. A second opinion can be useful before major cancer, cardiac, brain or spine surgery, joint replacement, organ transplantation, long-term chemotherapy, radiation therapy or complex fertility treatment.
A second opinion should not unnecessarily delay urgent treatment. International treatment is not automatically appropriate when the patient is medically unstable, cannot safely fly, or when appropriate treatment is already available locally.
The hospital should be selected around the patient's condition. Complex cases may require a subspecialist. Patients should understand the proposed treatment and its purpose.
Yes. Uzbek citizens can travel to India for medical treatment and are currently included in India's official e-Visa eligible-country list.
Yes. Uzbekistan appears on the Government of India's current official e-Visa eligible-country list, and the e-Visa system includes an e-Medical Visa category. The official fee list currently shows Uzbekistan at US$80.
The current official guidance says eligible e-Medical and e-Medical Attendant applicants can apply online at least four days before arrival, with a 120-day application window.
The current official portal lists e-Medical and e-Medical Attendant visas as one-year visas from arrival with multiple entries. Patients should verify the live portal before applying.
Yes. Eligible family members or attendants can apply for an e-Medical Attendant Visa. The current official guidance allows two e-Medical Attendant Visas against one e-Medical Visa.
Uzbekistan is not listed among yellow-fever endemic countries on India's IHR points-of-entry guidance. A certificate can still be required if the traveller has recently been in, or transited landside through, a listed endemic country.
The Embassy currently states that e-Visa stands restored to Uzbek nationals in all five sub-categories, including e-Medical and e-Medical Attendant, and directs applicants to the official Government of India e-Visa portal. Other visa categories can be submitted at the Embassy counter in Tashkent.
There is no fixed price. Cost depends on diagnosis, treatment, hospital, specialist, medicines, investigations, implants, ICU care and length of stay. GAF presents USD planning estimates, not guaranteed hospital quotations.
GLOBOCAN 2024 estimates 38,465 new cancer cases and 22,509 cancer deaths in Uzbekistan. The leading sites by estimated new cases among both sexes were breast, colorectum, cervix, prostate and stomach. These are population-level estimates, not an individual diagnosis.
Yes. Indian oncology centres provide surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, precision oncology and other treatments depending on the diagnosis and clinical indication.
Yes. Medical records can be submitted for preliminary specialist review and an indicative hospital estimate can be requested.
Yes. Patients from Tashkent, Samarkand, Bukhara, Andijan, Fergana, Namangan and other parts of Uzbekistan can share records before travel. Indian hospitals may request English translations of important Uzbek- or Russian-language records.
Yes. Patients from Samarkand, Bukhara, Andijan, Fergana, Namangan, Qarshi, Nukus, Termez and other regions can use the same medical-treatment pathway, subject to applicable travel and visa requirements.
Yes. Medical records can be shared with an appropriate Indian specialist for preliminary second-opinion review before travel. A remote opinion does not replace an in-person examination when one is clinically necessary.
There is no universal best city. Delhi NCR, Mumbai, Chennai, Hyderabad and Bengaluru are live GAF catalogue cities. Pune can also be considered, but this page does not link to a Pune directory because that city is not yet in the live catalogue. The appropriate city depends on the diagnosis and required specialty.
The duration depends on the treatment. A consultation may require a short visit, while surgery, radiation therapy, chemotherapy or transplantation may require a substantially longer stay.
Yes. Official MEA records identify pharmaceutical and healthcare as a high-priority area, record a Joint Working Group on Pharmaceutical and Healthcare, note 2018 agreements covering health and medical science and pharmaceuticals, and describe Uzbekistan as a significant source of medical tourism to India, with about 8,000 Uzbek patients annually seeking treatment in India in the published bilateral data.
Yes. India's Ministry of External Affairs has described Uzbekistan as a significant source of medical tourism to India and reported approximately 8,000 Uzbek patients annually seeking medical treatment in India in its bilateral brief. These are published figures, not a live 2026 patient count.
They can be submitted for preliminary coordination, but Indian hospitals may request English translations of important records. Pathology, imaging and treatment summaries are particularly important.
Communication support can be coordinated where required. Indian hospitals generally use English for clinical communication, so Uzbek- or Russian-language assistance can be useful for complex treatment.
Yes. Indian cardiac centres provide procedures including angioplasty, CABG, valve surgery, electrophysiology and other cardiac treatments, subject to specialist assessment.
Yes. Indian fertility centres provide IVF, ICSI, IUI, embryo-transfer procedures and other fertility services subject to medical and applicable legal requirements. GAF does not yet publish a dedicated IVF page.
No. International treatment is not automatically appropriate when the patient is medically unstable, cannot safely fly, needs immediate local treatment, or when the expected benefit does not justify the burden of travel.
Coverage depends on the patient's policy. Confirm whether planned treatment abroad, India, surgery, cancer treatment, medicines, emergency care and medical evacuation are covered, and obtain written confirmation where possible.
Not necessarily. A preliminary estimate is based on the information available before treatment. The final plan and cost can change after examination and investigation in India.
If you or a family member in Uzbekistan is considering treatment in India, the most useful first step is to share the patient's medical information. Send the diagnosis, medical reports, scans and previous treatment records to GAF Healthcare.
Share your medical records → Get a specialist opinion → Review hospital and treatment options → Plan your journey to India
This page is intended for general education and medical-travel planning. It does not replace advice from a qualified healthcare professional. Cancer statistics are population-level estimates and cannot determine an individual's diagnosis or prognosis. Treatment costs are indicative and can change. Visa requirements, fees, documentation and immigration regulations can change. Uzbek patients should verify the latest requirements on the official Government of India e-Visa portal before travelling.
Last reviewed: October 2026
